Literature DB >> 13725182

[Problems posed by the use of streptomycin in the treatment of gonococcal infection].

P DUREL, V ROIRON, L DELOUCHE.   

Abstract

Entities:  

Keywords:  GONORRHEA/therapy; STREPTOMYCIN/therapy

Mesh:

Substances:

Year:  1961        PMID: 13725182      PMCID: PMC2555399     

Source DB:  PubMed          Journal:  Bull World Health Organ        ISSN: 0042-9686            Impact factor:   9.408


× No keyword cloud information.
  3 in total

1.  Effects of penicillin, streptomycin, and tetracycline on N. gonorrhoeae isolated in 1944 and in 1957.

Authors:  A REYN; B KORNER; M W BENTZON
Journal:  Br J Vener Dis       Date:  1958-12

2.  [Masking of syphilis by penicillin; critical study and practical consequences].

Authors:  P DUREL; N HARDY
Journal:  Rev Hyg Med Soc       Date:  1957 Apr-May

3.  Sensitivity of strains of gonococci to penicillin, sulphathiazole, and streptomycin.

Authors:  J E CRADOCK-WATSON; R A SHOOTER; C S NICOL
Journal:  Br Med J       Date:  1958-05-10
  3 in total
  6 in total

1.  LABORATORY DIAGNOSIS OF GONOCOCCAL INFECTIONS.

Authors:  A REYN
Journal:  Bull World Health Organ       Date:  1965       Impact factor: 9.408

Review 2.  A survey of problems in the antibiotic treatment of gonorrhoea. With special reference to South-East Asia.

Authors:  R R Willcox
Journal:  Br J Vener Dis       Date:  1970-06

3.  Relapse of gonorrhoea after treatment with penicillin or streptomycin.

Authors:  A J Evans
Journal:  Br J Vener Dis       Date:  1966-12

4.  Secnidazole. A 5-nitroimidazole derivative with a long half-life.

Authors:  D Videau; G Niel; A Siboulet; F Catalan
Journal:  Br J Vener Dis       Date:  1978-04

5.  A study of the relationships between the sensitivities of Neisseria gonorrhoeae to sodium penicillin G, four semi-synthetic penicillins, spiramycin, and fusidic acid.

Authors:  A Reyn; M W Benzon
Journal:  Br J Vener Dis       Date:  1968-06

6.  TREATMENT OF URETHRITIS IN MALES WITH OXYTETRACYCLINE.

Authors:  L SYLVESTRE; J ETHIER
Journal:  Can Med Assoc J       Date:  1963-12-14       Impact factor: 8.262

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.